June 1, 2026

Stevanato Group S.p.A. (STVN) Stock Analysis: An Under-the-Radar Healthcare Gem with 33% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN) stands out as a significant player in the healthcare sector, specifically in the medical instruments and supplies industry. Headquartered in Piombino Dese, Italy, the company..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 40% Potential Upside in the Healthcare Sector

Prestige Consumer Healthcare Inc. (NYSE: PBH), a notable player in the healthcare sector, is attracting attention from investors due to its substantial potential upside. The company, with a market capitalization..

Bausch + Lomb Corporation (BLCO) Investor Outlook: Analyzing Growth Potential with a 14% Upside

Bausch + Lomb Corporation (NYSE: BLCO), a prominent player in the healthcare sector, specializes in medical instruments and supplies, primarily focusing on eye health. With a market capitalization of $5.58..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a 61.62% Potential Upside with Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, is garnering significant attention from investors. With a market capitalization of $4.37..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Potential 26.52% Upside Amid Robust Revenue Growth

TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves in the biotechnology sector with its strong focus on developing innovative treatments for B-cell mediated diseases. As a commercial-stage biopharmaceutical company, TG..

Illumina, Inc. (ILMN) Stock Analysis: Understanding the Growth Potential Amidst a Robust Market Cap

Illumina, Inc. (NASDAQ: ILMN), a prominent player in the diagnostics and research industry, is captivating investor attention with its significant market cap of $24.66 billion. The company, headquartered in San..

Zoetis Inc. (ZTS) Stock Analysis: Unveiling a 60% Potential Upside in the Healthcare Sector

Zoetis Inc. (NYSE: ZTS), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is capturing investors’ attention with its promising 60.37% potential upside...

Masimo Corporation (MASI) Stock Analysis: Evaluating the Healthcare Innovator’s Performance and Growth Potential

Masimo Corporation (MASI), a key player in the healthcare sector’s medical devices industry, has long been at the forefront of patient monitoring technology. With a market capitalization of $9.35 billion,..

Solventum Corporation (SOLV) Stock Analysis: Strong Return on Equity and Investor Ratings Signal Potential Growth

Solventum Corporation (NASDAQ: SOLV), a key player in the healthcare sector with a focus on medical instruments and supplies, presents an intriguing opportunity for investors seeking a blend of innovation..

Elanco Animal Health (ELAN) Stock Analysis: 24.89% Potential Upside Beckons Investors

Elanco Animal Health Incorporated (NYSE: ELAN), a key player in the healthcare sector focusing on specialty and generic drug manufacturing, presents an intriguing opportunity for investors eyeing the animal health..

Guardant Health, Inc. (GH) Stock Analysis: Navigating the Rapid Growth in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH), a frontrunner in the rapidly evolving field of precision oncology, continues to capture the attention of investors with its promising growth trajectory and innovative diagnostic..

Merit Medical Systems (MMSI) Stock Analysis: Exploring a 43.73% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector, is emerging as a promising opportunity for investors seeking exposure to the Medical Instruments & Supplies industry...

TransMedics Group, Inc. (TMDX) Stock Analysis: A 73.78% Potential Upside in the Medical Devices Sector

TransMedics Group, Inc. (NASDAQ: TMDX) has emerged as a compelling player in the highly specialized field of organ transplant technology. This Andover, Massachusetts-based company is making waves in the medical..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 109.90% Potential Upside Amid Robust Revenue Growth

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is capturing investor attention due to its significant potential upside of 109.90%, as reflected in analyst price targets...

Integer Holdings Corporation (ITGR) Stock Analysis: Potential Upside and Strong Buy Ratings in the Medical Device Sector

Investors eyeing the healthcare sector might find Integer Holdings Corporation (NYSE: ITGR) an intriguing opportunity with its robust position in the medical device industry. With a market capitalization of $3.03..

Danaher Corporation (DHR) Stock Analysis: Exploring a 34% Potential Upside Amid Strong Buy Ratings

Danaher Corporation (NYSE: DHR), a stalwart in the healthcare sector, continues to capture the attention of investors with its solid performance and promising growth potential. Operating through its biotechnology, life..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Healthcare Giant with a 17.86% Upside Potential

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands as a prominent player in the healthcare sector, specializing in medical devices. With a market capitalization of $12.62 billion, this UK-based company..

Royalty Pharma plc (RPRX) Stock Analysis: Evaluating Its 6.26% Potential Upside and Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector, not just for its unique business model as a buyer of biopharmaceutical royalties but also for its robust market..

Cardinal Health, Inc. (CAH) Stock Analysis: Capitalizing on a 24.63% Potential Upside

Cardinal Health, Inc. (CAH) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. Headquartered in Dublin, Ohio, this Fortune 500 company operates globally, offering..

Alkermes plc (ALKS) Stock Analysis: Solid Growth Potential with 28.2% Revenue Surge and Analyst Consensus

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, operates within the specialty and generic drug manufacturing industry. Headquartered in Dublin, Ireland, Alkermes has carved a niche for..

Search

Funds

June 1, 2026

Search

Funds

June 1, 2026

FTSE 100

Funds